A case report highlights rituximab-induced Crohn's disease-like colitis in a patient treated for post-transplant lymphoproliferative disorder associated with chronic active Epstein-Barr virus infection. This finding may inform clinicians about potential gastrointestinal complications following rituximab therapy.
rituximab induced crohn s disease like colitis following treatment for post transplant lymphoproliferative disorder in chronic active epstein barr virus infection a case report
Original title: “Rituximab-Induced Crohn's Disease-like Colitis Following Treatment for Post-transplant Lymphoproliferative Disorder in Chronic Active Epstein-Barr Virus Infection: A Case Report.”